Compound ID | 38
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Broad spectrum activity |
| Institute where first reported: | Department of Pharmacy, CIRPEB, and DFM, University of Naples Federico II, Naples, Italy |
| Year first mentioned: | 2009 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |